An Essential Overview of the Pharmaceutical and Biotech Industries

This programme will give you an invaluable overview of the Pharmaceutical industry, from discovery of the molecule through development to marketing

20 May 2019

& 21 Oct 2019

GBP 699
EUR 979
USD 1,090

Book now

Course overview

This programme will give you an invaluable overview, refresher and update on the pharmaceutical and biotechnology industries, from discovery of the molecule through development to marketing. It will provide a step-by-step understanding of the main areas of drug development and will discuss the roles and responsibilities of key staff involved. You will be given a comprehensive glossary of the most commonly used industry terms, which will be an invaluable reference to help you
get to grips with the technical terminology and jargon.

Book both

This meeting runs back-to-back with An Essential Overview of the Medical Devices Industry and there is a further £100/€140 discount when booked with An Essential Overview of the Pharmaceutial and Biotech Industries.

To register on both events click HERE

To find out more call Customer Services on +44 (0)20 7749 4730 or e-mail

Who should attend

All those wanting to achieve a better understanding of how the pharma/biotech industries work. The course will be particularly helpful for those wanting to understand what other departments do, for new staff working in the industry and for non-scientific and administrative personnel.

Why you should attend

  • Increase your understanding of the pharma/biotech industries
  • Develop your knowledge of the stages of drug development from drug discovery through to marketing
  • Get to grips with the phases of clinical trials, regulatory processes and pharmacovigilance requirements
  • Understand the roles and responsibilities of key departments and how they work together
  • Demystify the technical terminology and jargon


How the pharma/biotech industries develop medicines

  • Overview of drug development and why we patent drugs
  • The difference between a pharmaceutical and a biotechnology company
  • Drug discovery
  • Non-clinical/pre-clinical
    – the importance of examining safety

Demystifying the jargon and terminology

What are the roles and responsibilities of the people in the pharma/biotech industries?

Clinical trials

  • Gaining a clear picture of what happens at each phase of clinical research: Phase I – Phase IV
  • Ensuring the quality of the data: monitoring, auditing and working to ICH


  • What is pharmacovigilance?
  • Overview of safety reporting, signal detection, evaluation and risk management

Regulatory processes

  • Overview of regulatory submissions and approval procedures, including EU accelerated procedures
  • The importance of ICH
  • The electronic Common Technical Document (eCTD)
  • The EU Clinical Trial Regulation
  • The impact of Brexit

How are medicines marketed and sold?


Laura Brown

Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.

Book now

20 May 2019
20 May 2019 Rembrandt Hotel, London GBP 699.00
EUR 979.00
USD 1,090.00
+ VAT @ 20.00%
Enrol now
21 Oct 2019
21 Oct 2019 Rembrandt Hotel, London GBP 699.00
EUR 979.00
USD 1,090.00
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • (MHRA) Medicines & Healthcare Products Regulatory Agency
  • Abbott Products Operations AG
  • Arriello Ireland Limited
  • Bayer
  • Bayer Public Limited Company
  • BD Pharmaceutical System
  • Biogen Idec Limited
  • Brecon Anderson UK Ltd
  • Charles Russell Speechlys LLP
  • Chugai Pharma UK Ltd
  • Digiweb Ltd
  • F Hoffmann La Roche Ltd
  • GW Pharmaceuticals
  • Hospira UK Ltd
  • Intercept Pharmaceuticals
  • IPSEN Pharma
  • Janssen
  • MHRA
  • Monachem
  • Mundipharma Research Limited
  • Pharmiweb Solutions
  • Pliva Croatia d.o.o.
  • Presspart
  • Ridge Pharma
  • Shire Pharmaceuticals
  • Sunovion Pharmaceuticals Europe
  • TauRx Therapeutics Ltd
  • UCB Biopharma SPRL
  • Vertex Pharmaceuticals (Europe) Limited

Very well organised course, with a very knowledgable and friendly presenter giving clear and concise information. Very useful to people new to the industry and a good revision for others.

Shona Rhydderch, Analytical Chemist, TauRx Therapeutics Ltd

Very good content, engaging speaker

Yasmin Hubbard, Admin Associate III, International Medical Affairs, Vertex Pharmaceuticals (Europe) Limited

Very enjoyable overall, I feel this will help my learning and development

Tanya Killick, Medical Administrative Associate, Vertex Pharmaceuticals (Europe) Limited

Very informative. The speaker kept everyone engaged by involving them in group task was a good way to interact and learn more about other areas of the industry

Kit Graham, Warehouse Operative, GW Pharm

The course was great, well prepared and well spoken.

Monica Milani, Redacteur Scientifique , GALDERMA Recherche & Developpement

All areas were excellent. The booklet accompanying the presentation was very helpful

Grace McIntyre, Warehouse Technician, GW Pharmaceuticals

Overall I am very happy with the course

Paul Fitton, Regulatory Affairs Specialist, Presspart

I felt that a newbie to Pharmaceuticals it was a perfect course for me to have a overview without being too complicated. There was a lot to cover and I think Laura delivered the course well and was happy to answer questions when asked.

Sharon Shoveller, Supply Chain Distribution Administrator, GW Pharma Ltd

The course was insightful and carefully structured. The presentation was basic and effective through powerpoint. The speaker was excellent, clear and concise.

Dhirenkumar Mistry, Marketing, Arriello Ireland Limited

Very good course- I would recommend to my colleagues

Hayley West, Preclinical Coordinator , GW Pharmaceuticals

I thought the course was good and I liked the fact that we was able to get to work with different people. The presentation was good, it was broken down step by step to give everyone a better understand and it was very easy to follow. The speaker was very professional.

Cher Kelly, Document Control Assistant , GW pharma

Excellent, best course I have been on to date

Sharna King, , G Pharm

Very good content, but not enough time to discuss in more details, or to ask more questions

Sophie Ferruit, Scientific writer, Monachem

The content and presentation were interesting and followed a logic pattern. The speaker was very clear and engaging.

Quazi Hussain, Vigilance Risk Management Student Placement, Mundipharma Research Limited

I thought the content was appropriate and very well presented but there was a lot to cover in one day. I thought Laura was excellent and presented very well and I thought the execution of the event was run smoothly and efficiently by Management Forum.

Susan Delaney, National Scientific Advice Administrator, Medicines and Healthcare Products Regulatory Agency (MHRA)

All areas well covered, all questions answered. Pleasant speaker.

Leanne Gosling, , Bayer